UroGen Pharmaceuticals Ltd - Company Review
UroGen Pharmaceuticals Ltd - Company ReviewSummary
UroGen Pharmaceuticals Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladder cancer, carcinoma in situ bladder cancer and low grade upper tract urothelial carcinoma. It utilizes proprietary platform technologies such as RTGel, reverse thermal gelation hydrogel for managing formulations of chemotherapy; and immunotherapy technology to develop immune-modulation drug candidates. The company operates in Israel and the US. UroGen Pharma is headquartered in Ra'anana, Israel.
This comprehensive company report of UroGen Pharmaceuticals Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.